MitraClip Percutaneous Mitral Valve Repair Introduction to the
... 1.Reichenspurner, H. et al. Clinical Outcomes through 12 months in patients with Degenerative Mitral Regurgitation treated with the MitraClip device in the ACCESS-Europe Phase I trial. Eur J Cardiothoracic Surgery. 2013: 44:e 280-288. 2. Franzen O, Baldus S, Rudolph V, et al. Acute outcomes of Mitra ...
... 1.Reichenspurner, H. et al. Clinical Outcomes through 12 months in patients with Degenerative Mitral Regurgitation treated with the MitraClip device in the ACCESS-Europe Phase I trial. Eur J Cardiothoracic Surgery. 2013: 44:e 280-288. 2. Franzen O, Baldus S, Rudolph V, et al. Acute outcomes of Mitra ...
Acute heart failure in the intensive care unit - Area
... heart failure in the opinion of the attending physician in 2001 (12). Patients admitted directly to the general ward were not included in the survey. Follow-up was conducted at 4 wks and 12 months. Characteristics of Patients Admitted With Acute Heart Failure. Table 2 and 3 allow comparison of the c ...
... heart failure in the opinion of the attending physician in 2001 (12). Patients admitted directly to the general ward were not included in the survey. Follow-up was conducted at 4 wks and 12 months. Characteristics of Patients Admitted With Acute Heart Failure. Table 2 and 3 allow comparison of the c ...
Placement of Central Catheters in Patients with
... different cardiac and central venous vascular anomalies if one is aware of the vascular anatomy and cardiac malformation and base some information about the different operations to “correct” congenital heart disease. Placement of central catheters in patients with cardiac and central venous vascular ...
... different cardiac and central venous vascular anomalies if one is aware of the vascular anatomy and cardiac malformation and base some information about the different operations to “correct” congenital heart disease. Placement of central catheters in patients with cardiac and central venous vascular ...
Chapter 19 Circulartory System
... the SA node – ectopic foci - region of spontaneous firing • nodal rhythm – if SA node is damaged, heart rate is set by AV node, 40 to 50 bpm • intrinsic ventricular rhythm – if both SA and AV nodes are not functioning, rate set at 20 to 40 bpm – this requires pacemaker to sustain life ...
... the SA node – ectopic foci - region of spontaneous firing • nodal rhythm – if SA node is damaged, heart rate is set by AV node, 40 to 50 bpm • intrinsic ventricular rhythm – if both SA and AV nodes are not functioning, rate set at 20 to 40 bpm – this requires pacemaker to sustain life ...
Print - Circulation
... 50); 21 (78%) were men and six were women. Angina pectoris had been present from one to 120 months (average 25): for less than one year in 12 and for more than three years in five. Systemic hypertension (> 140/90 mm Hg) was recorded at some time in 11 patients (41%) and in all it was intermittent; 2 ...
... 50); 21 (78%) were men and six were women. Angina pectoris had been present from one to 120 months (average 25): for less than one year in 12 and for more than three years in five. Systemic hypertension (> 140/90 mm Hg) was recorded at some time in 11 patients (41%) and in all it was intermittent; 2 ...
Theory
... electrical signals, or abnormal rhythms caused by electrolyte imbalances. In a myocardial infarction (MI), the ECG can identify if the heart muscle has been damaged in specific areas, though not all areas of the heart are covered. The ECG cannot reliably measure the pumping ability of the heart, for ...
... electrical signals, or abnormal rhythms caused by electrolyte imbalances. In a myocardial infarction (MI), the ECG can identify if the heart muscle has been damaged in specific areas, though not all areas of the heart are covered. The ECG cannot reliably measure the pumping ability of the heart, for ...
ECG interpretation for beginners * 2 Axel en Luc De Wolf
... The “golden hour”: 65 lives are saved for every 1,000 patients treated when the treatment is initiated within the first hour of symptom onset! ...
... The “golden hour”: 65 lives are saved for every 1,000 patients treated when the treatment is initiated within the first hour of symptom onset! ...
Pregnancy and heart disease - International Journal of
... during pregnancy is not possible.7,10 Hemodynamic monitoring during labour and delivery with a pulmonary artery catheter is recommended in all patients with moderate and severe MS.11 Optimization of left atrial pressure before delivery may be needed and can be achieved by diuresis and reduction of h ...
... during pregnancy is not possible.7,10 Hemodynamic monitoring during labour and delivery with a pulmonary artery catheter is recommended in all patients with moderate and severe MS.11 Optimization of left atrial pressure before delivery may be needed and can be achieved by diuresis and reduction of h ...
270 Original article Clinical profile of patients with Total Anomalous
... connection occurs to the portal vein, venous duct, or inferior vena cava below the diaphragm. With type IV, a mixed site variety (5%), the anomalous venous return occurs at several levels 1. Pathophysiologically, these four types are sub classified according to whether the pulmonary venous return is ...
... connection occurs to the portal vein, venous duct, or inferior vena cava below the diaphragm. With type IV, a mixed site variety (5%), the anomalous venous return occurs at several levels 1. Pathophysiologically, these four types are sub classified according to whether the pulmonary venous return is ...
Lehmann, Ketty Schwartz, Philippe Coumel and Raffaella Bloise
... conditions (“triggers”) associated with cardiac events may in large part be gene specific. Methods and Results—We identified 670 LQTS patients of known genotype (LQT1, n⫽371; LQT2, n⫽234; LQT3, n⫽65) who had symptoms (syncope, cardiac arrest, sudden death) and examined whether 3 specific triggers (e ...
... conditions (“triggers”) associated with cardiac events may in large part be gene specific. Methods and Results—We identified 670 LQTS patients of known genotype (LQT1, n⫽371; LQT2, n⫽234; LQT3, n⫽65) who had symptoms (syncope, cardiac arrest, sudden death) and examined whether 3 specific triggers (e ...
Sudden Cardiac Death in the Young: A Strategy for Prevention by
... Arrhythmic risk in the cardiomyopathies and inherited arrhythmia syndromes may be significant without concurrent systolic dysfunction or debilitating symptoms. Anti-arrhythmic therapy has been shown to confer a survival benefit in certain contexts, such as the use of -blockers in the LQT1 subtype of ...
... Arrhythmic risk in the cardiomyopathies and inherited arrhythmia syndromes may be significant without concurrent systolic dysfunction or debilitating symptoms. Anti-arrhythmic therapy has been shown to confer a survival benefit in certain contexts, such as the use of -blockers in the LQT1 subtype of ...
AANA Journal Course - American Association of Nurse Anesthetists
... on the epicardial surface that functioned as pacing leads. These early devices were set at a constant rate, could not be programmed individually, and were capable of ventricular pacing only; the lack of sensing of the patient’s intrinsic rhythm meant that the device actually competed with the patien ...
... on the epicardial surface that functioned as pacing leads. These early devices were set at a constant rate, could not be programmed individually, and were capable of ventricular pacing only; the lack of sensing of the patient’s intrinsic rhythm meant that the device actually competed with the patien ...
Mitochondrial Cytopathies and Cardiac Disease
... o The myocytes contain high numbers of mitochondria (1000’s per cell), which account for about 20-40% of the cell volume. o In the fetal heart, glucose and lactate are the primary fuel sources for energy production. o After birth, fatty acids become the primary energy source and their metabolism ac ...
... o The myocytes contain high numbers of mitochondria (1000’s per cell), which account for about 20-40% of the cell volume. o In the fetal heart, glucose and lactate are the primary fuel sources for energy production. o After birth, fatty acids become the primary energy source and their metabolism ac ...
Exercise Capacity in Patients with Severe Left Ventricular Dysfunction
... referred patients with coronary artery disease optimally treated with digitalis, diuretics and vasodilators. Therefore, extrapolating our findings to patients with various untreated cardiac ailments would be inappropriate even if the severity of left ventricular dysfunction were similar. Also, our s ...
... referred patients with coronary artery disease optimally treated with digitalis, diuretics and vasodilators. Therefore, extrapolating our findings to patients with various untreated cardiac ailments would be inappropriate even if the severity of left ventricular dysfunction were similar. Also, our s ...
- Wiley Online Library
... in-hospital mortality was not different in men and women at any level of predicted risk based on admission variables. This finding is clinically significant because previous reports have suggested that female gender is associated with a lower mortality risk.31–38 These previous studies were largely ...
... in-hospital mortality was not different in men and women at any level of predicted risk based on admission variables. This finding is clinically significant because previous reports have suggested that female gender is associated with a lower mortality risk.31–38 These previous studies were largely ...
Heart Failure with Preserved Ejection Fraction
... structure and function that are pertinent to HFpEF patients. Aging reduces the diastolic filling rate as a result of prolonged relaxation, which results in left atrial overload and pulmonary venous hypertension. Arterial stiffness increases with age, resulting in increased afterload and load-depende ...
... structure and function that are pertinent to HFpEF patients. Aging reduces the diastolic filling rate as a result of prolonged relaxation, which results in left atrial overload and pulmonary venous hypertension. Arterial stiffness increases with age, resulting in increased afterload and load-depende ...
Oscillatory Ventilation During Exercise in Patients With Chronic
... Study population: We studied 323 patients with chronic heart failure and left ventricular ejection fraction (LVEF) < 40%. Measurements and results: All patients performed a symptom-limited cardiopulmonary exercise test and were followed up for 22 ⴞ 11 months (mean ⴞ SD). EOV was defined as cyclic fl ...
... Study population: We studied 323 patients with chronic heart failure and left ventricular ejection fraction (LVEF) < 40%. Measurements and results: All patients performed a symptom-limited cardiopulmonary exercise test and were followed up for 22 ⴞ 11 months (mean ⴞ SD). EOV was defined as cyclic fl ...
The Prognosis of Primary Percutaneous Coronary Intervention after
... avoid unacceptable time delays, STEMI guidelines as well as recent overviews have outlined the importance of organized systems of care network in order to shorten the time delay from electrocardiogram (ECG) diagnosis, as the first medical contact, to the first balloon dilatation in an efficient cath ...
... avoid unacceptable time delays, STEMI guidelines as well as recent overviews have outlined the importance of organized systems of care network in order to shorten the time delay from electrocardiogram (ECG) diagnosis, as the first medical contact, to the first balloon dilatation in an efficient cath ...
Spontaneous resolution of ventricular tachycardia with right bundle
... pathways are the postulated mechanisms1 . Two clinical forms have often been observed: (1) verapamil-sensitive VT characterized by right bundle branch block (RBBB) morphology with superior frontal plane axis, and (2) catecholamine-sensitive VT characterized by left bundle branch block (LBBB) morphol ...
... pathways are the postulated mechanisms1 . Two clinical forms have often been observed: (1) verapamil-sensitive VT characterized by right bundle branch block (RBBB) morphology with superior frontal plane axis, and (2) catecholamine-sensitive VT characterized by left bundle branch block (LBBB) morphol ...
Full text PDF
... dbase-based software. Databases were stored with a central data manager at the Scientific Institute of Public Health. Several control measures ensured data quality and limited missing data. Data cleaning and data analyses for this study were performed using SPSS17.0 (SPPS Inc). Univariate associatio ...
... dbase-based software. Databases were stored with a central data manager at the Scientific Institute of Public Health. Several control measures ensured data quality and limited missing data. Data cleaning and data analyses for this study were performed using SPSS17.0 (SPPS Inc). Univariate associatio ...
with Atrial Fibrillation (AFib)
... Because the heart beats irregularly during AFib, it affects the way blood flows through the heart and makes it vulnerable for forming clots. Such clots can travel from the heart to the brain where they can block vital blood flow—resulting in a stroke that can be debilitating or deadly. The risk of s ...
... Because the heart beats irregularly during AFib, it affects the way blood flows through the heart and makes it vulnerable for forming clots. Such clots can travel from the heart to the brain where they can block vital blood flow—resulting in a stroke that can be debilitating or deadly. The risk of s ...
p-wave
... 6 mg administered rapidly over 1-3 seconds followed by a 20 ml NS bolus. does not convert out of SVT within 1 to 2 minutes, a second 12 mg dose may be given in similar fashion. Administer adenosine as quickly as possible. side effects -flushing, chest pain/tightness, brief asystole or bradycar ...
... 6 mg administered rapidly over 1-3 seconds followed by a 20 ml NS bolus. does not convert out of SVT within 1 to 2 minutes, a second 12 mg dose may be given in similar fashion. Administer adenosine as quickly as possible. side effects -flushing, chest pain/tightness, brief asystole or bradycar ...
aVR ST-segment elevation during narrow QRS complex tachycardia
... The fQRS is an independent predictor of cardiac events in patients with CAD. It is associated with significantly lower event-free survival for a cardiac event on long-term follow-up(3). However, fQRS is not specific for CAD and is also encountered in other myocardial diseases such as cardiomyopathy ...
... The fQRS is an independent predictor of cardiac events in patients with CAD. It is associated with significantly lower event-free survival for a cardiac event on long-term follow-up(3). However, fQRS is not specific for CAD and is also encountered in other myocardial diseases such as cardiomyopathy ...
Clinical and Genetic Heterogeneity of Right Bundle Branch Block
... Methods and Results—Sixty patients (45 males aged 40⫾15 years) with the typical ECG pattern were clinically evaluated. Events at follow-up were analyzed for patients with at least one episode of aborted sudden death or syncope of unknown origin before recognition of the syndrome (30 symptomatic pati ...
... Methods and Results—Sixty patients (45 males aged 40⫾15 years) with the typical ECG pattern were clinically evaluated. Events at follow-up were analyzed for patients with at least one episode of aborted sudden death or syncope of unknown origin before recognition of the syndrome (30 symptomatic pati ...
Cardiac contractility modulation
.jpg?width=300)
Cardiac contractility modulation (CCM) is a treatment for patients with moderate to severe left ventricular systolic heart failure (NYHA class II–IV). The short- and long-term use of this therapy enhances both the strength of ventricular contraction and the heart’s pumping capacity. The CCM mechanism is based on stimulation of the cardiac muscle by non-excitatory electrical signals (NES). CCM treatment is delivered by a pacemaker-like device that applies the NES, adjusted to and synchronized with the electrical action in the cardiac cycle.In CCM therapy, electrical stimulation is applied to the cardiac muscle during the absolute refractory period. In this phase of the cardiac cycle, electrical signals cannot trigger new cardiac muscle contractions, hence this type of stimulation is known as a non-excitatory stimulation. However, the electrical CCM signals increase the influx of calcium ions into the cardiac muscle cells (cardiomyocytes). In contrast to other electrical stimulation treatments for heart failure, such as pacemaker therapy or implantable cardioverter defibrillators (ICD), CCM does not affect the cardiac rhythm directly. Rather, the aim is to enhance the heart’s natural contraction (the native cardiac contractility) sustainably over long periods of time. Furthermore, unlike most interventions that increase cardiac contractility, CCM is not associated with an unfavorable increase in oxygen demand by the heart (measured in terms of Myocardial Oxygen Consumption or MVO2). This may be explained by the beneficial effect CCM has in improving cardiac efficiency. A meta-analysis in 2014 and an overview of device-based treatment options in heart failure in 2013 concluded that CCM treatment is safe, that it is generally beneficial to patients and that CCM treatment increases the exercise tolerance (ET) and quality of life (QoL) of patients. Furthermore, preliminary long-term survival data shows that CCM is associated with lower long-term mortality in heart failure patients when compared with expected rates among similar patients not treated with CCM.